COMT and Chronic Pain Susceptibility
Empower Your Health Journey: Log In to Discover Your Genetic Insights
Chronic pain affects over 50 million Americans, making it one of the most common reasons adults seek medical care. The causes behind chronic pain syndromes like fibromyalgia, migraines, and irritable bowel syndrome have long mystified doctors. While these conditions seem unrelated, emerging research reveals they may share common genetic factors that influence pain perception.
Studies show genetics accounts for 50% of an individual's pain sensitivity. The main player is the COMT gene which codes for the COMT enzyme that degrades brain chemicals like dopamine and norepinephrine. The most studied COMT variant is Val158Met. Those with Val/Val experience less pain while Met/Met individuals have higher pain sensitivity.
Up to 75% of fibromyalgia patients carry the Met/Met variant. This COMT phenotype is also prevalent among people with migraines and irritable bowel syndrome, which frequently overlap with fibromyalgia. The COMT connection likely explains why these conditions often co-occur.
How does COMT lead to chronic pain? The Met/Met variant is associated with substantially higher dopamine and norepinephrine levels in the brain and body. This amplifies pain signals and leads to central sensitization over time, characteristic of many chronic pain disorders.
Other genes linked to heightened pain perception include those affecting the brain's natural opioid system, the major neurotransmitter GABA, and inflammatory cytokines. While COMT may increase susceptibility, development of chronic pain requires a combination of genetic and lifestyle factors like injury, stress, and poor sleep habits.
- Recent research found the Val158Met polymorphism accounts for about 10% of variability in pain sensitivity - meaningful but showing genetics are just one piece of the puzzle.
- Though less studied, other gene variants like those regulating serotonin and endocannabinoids also influence pain perception and may interact with COMT.
- Brain imaging studies show Met/Met individuals have differences in how their brains process pain signals from the body. This neural signature may serve as a biomarker.
- While most studies focus on chronic pain in adults, there is emerging research on genetic factors in pediatric pain disorders like juvenile fibromyalgia.
- Some pain researchers argue personalized genetic testing may one day guide treatment, allowing doctors to predict who will respond best to specific pain medications based on genotype.
- Pharmaceutical companies are investigating new COMT-inhibiting drugs tailored to pain type and genetic profile to minimize side effects.
- Larger genome-wide association studies may uncover new genetic variations involved in pain and explain why some with high-risk variants stay pain-free.
- The epigenetics of pain is a new avenue of research, examining how genes are turned on/off by environmental stimuli and life experiences.
Though our genes do not define our destiny, understanding one's pain genetics can guide therapy. Relaxation techniques like meditation help lower catecholamine levels in Met/Met individuals. Some research indicates COMT inhibitors may benefit chronic pain, though more studies are needed. Diet and lifestyle changes can also optimize brain chemistry.
Knowledge of our biological risks empowers us to make informed choices and live well despite our genes.
Related Supplements
Here are some dietary supplements related to the content in this report. Click the shopping cart to purchase the supplement from our partners.
-
Curcumin (turmeric)
Shown to inhibit COMT activity and increase dopamine levels in the brain. Also has anti-inflammatory effects.
-
Omega-3 fatty acids (fish oil):
May reduce inflammation that contributes to pain. Also may protect neurons that use dopamine.
-
Magnesium
Required for COMT enzymatic reactions. Supplements may help for those deficient.
-
Rhodiola rosea
Herb that may inhibit COMT, especially in the Met/Met genotype. May prolong dopamine effects.
-
SAM-e
Supplement that provides methyl groups needed for COMT methylation reactions. May support COMT function.
-
Devil's claw
Natural anti-inflammatory that may reduce inflammatory pain. Also thought to interact with neurotransmitter systems.
-
Cayenne/Capsaicin
Compound found in hot chili peppers that depletes substance P, a neurotransmitter involved in pain signaling.
-
Valerian root
Herbal anxiolytic that may increase GABA, a neurotransmitter associated with reduced pain perception.
-
St. John's Wort
Herb that may inhibit COMT activity similar to some pain medications. Also boosts serotonin which improves mood.
-
Peppermint oil
Menthol is a COMT inhibitor. Peppermint oil applied topically may enhance painkilling dopamine effects.
-
Boswellia
Anti-inflammatory herb that may disrupt cytokine signaling implicated in pain hypersensitivity.
-
Cannabidiol (CBD)
Compound from cannabis that affects endocannabinoid receptors involved in pain processing.
-
DLPA
Supplement containing amino acids that may prevent breakdown of endorphins for natural pain relief.
-
5-HTP
Supplement that increases serotonin levels which may help with fibromyalgia and comorbid depression.
-
Ginger
Contains anti-inflammatory gingerols that may inhibit pain-causing prostaglandins and leukotrienes.
-
Arnica
Homeopathic pain remedy used topically that may reduce inflammation and impact serotonin.
Disclaimer